Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis
- 28 September 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 3 (12) , 959-964
Abstract
Cancer metastasis is a major barrier to its treatment and an important cause of patient death. Antimetastatic agents hold promise for patients with advanced metastatic tumors. Aminopeptidase N/CD13 (APN) is being pursued by many as an important target against cancer metastasis and angiogenesis, but there are few reports on the in vivo evaluation of synthetic APN inhibitors. Herein, a series of compounds targeting APN were synthesized and evaluated for their antimetastasis and antiangiogenesis potency both in vitro and in vivo. Excitingly, compounds 4m, 4t, and 4cc, with the most potent APN inhibitory activities, displayed significant antimetastasis and antiangiogenesis effects in vitro and in vivo, suggesting that those synthetic APN inhibitors have the potential to overcome cancer metastasis and angiogenesis.Keywords
This publication has 29 references indexed in Scilit:
- The physics of cancer: the role of physical interactions and mechanical forces in metastasisNature Reviews Cancer, 2011
- Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug developmentBioorganic & Medicinal Chemistry, 2011
- Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part IEuropean Journal of Medicinal Chemistry, 2009
- Oligomannurarate Sulfate, a Novel Heparanase Inhibitor Simultaneously Targeting Basic Fibroblast Growth Factor, Combats Tumor Angiogenesis and MetastasisCancer Research, 2006
- Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifyllineJournal of Cancer Research and Clinical Oncology, 2001
- Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequencesFEBS Letters, 1993
- Neutral surface aminopeptidase activity of human tumor cell linesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Inhibition of Tumor Cell Invasion by Ubenimex (Bestatin) in vitroJapanese Journal of Cancer Research, 1989
- In Vitro Degradation of Opioid Peptides by Human Placental Aminopeptidase MExperimental and Clinical Endocrinology & Diabetes, 1988
- Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.Journal of Experimental Medicine, 1975